Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1177/1078155213508442
dc.identifier.other
WOS:000346997900008
dc.description.volume
dc.description.issue
Publisher
SAGE PUBLICATIONS LTD
DOI
10.1177/1078155213508442